More on SABS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (9.1 Score)

Upcoming Events

- Earnings (11/7/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SAB Biotherapeutics (NQ:SABS)
Delayed: 3.79 -0.02 (0.52%)
Prev. Close $3.81  
Open$3.71 
52 Wk High$ 
52 Wk Low$ 
Day High$3.85 
Day Low$3.64 
P/E N/A  
EPS$ 
Volume155,920 

Friends, Peers and Foes (?): SABSW (more...)

Feb 17, 2026 04:24 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Feb 17, 2026 08:51 AM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: RTW INVESTMENTS, LP
Feb 5, 2026 04:55 PM Form 4 SAB Biotherapeutics, For: Feb 03 Filed by: Sullivan Eddie Joe
Feb 5, 2026 04:50 PM Form 4 SAB Biotherapeutics, For: Feb 05 Filed by: Reich Samuel J
Feb 5, 2026 04:45 PM Form 4 SAB Biotherapeutics, For: Feb 03 Filed by: Bausch Christoph Lawrence
Feb 5, 2026 04:40 PM Form 4 SAB Biotherapeutics, For: Feb 03 Filed by: Kropotova Alexandra
Feb 5, 2026 04:35 PM Form 4 SAB Biotherapeutics, For: Feb 03 Filed by: To Lucy
Jan 22, 2026 04:35 PM Form SCHEDULE 13G SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Jan 12, 2026 04:48 PM Form 8-K SAB Biotherapeutics, For: Jan 12
Jan 8, 2026 06:02 AM Form EFFECT SAB Biotherapeutics,
View All Articles

Entities mentioned with SABS

View All Entities